Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
05/2001
05/25/2001WO2001036426A1 Pyridinones to treat and prevent bacterial infections
05/25/2001WO2001036402A1 Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives
05/25/2001WO2001036401A1 Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-thiazolidinedione
05/25/2001WO2001036400A1 Method for producing 2-chloro-5-chloromethyl-1,3-thiazol
05/25/2001WO2001036398A1 Benzoxa- and benzthiazoles
05/25/2001WO2001036386A1 Diabetic remedy containing dipiperazine derivative
05/25/2001WO2001036365A2 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
05/25/2001WO2001035959A1 Use of thiazole derivatives for treatment/prevention of p38 kinase mediated disorders
05/25/2001WO2000077027A3 Serine protease inhibitors
05/25/2001CA2391429A1 Solid state forms of 5-¬¬6-¬(2-fluorophenyl)methoxy|-2-naphthalenyl|methyl|-2,4-thiazolidinedione
05/25/2001CA2390658A1 Pyridinones to treat and prevent bacterial infections
05/24/2001US20010001799 Anticoagulant
05/23/2001EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF
05/23/2001EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
05/23/2001EP1100790A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
05/23/2001EP1100485A1 Substituted anilide compounds and methods
05/23/2001EP0812835B1 Optically active thiazolidinone derivatives
05/23/2001EP0788497B1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
05/23/2001EP0689536B1 Naphthalene derivatives
05/23/2001CN1296005A Process for preparing 5-methyl-2-thiazoamine
05/22/2001US6235790 Hydroxamic-acid derivatives, method of preparing them and their use as fungicides
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235768 Osteoporosis; rheumatic disorders; antitumor agents
05/22/2001US6235763 Therapy for eating disorders
05/22/2001US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens
05/17/2001WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001WO2001034585A1 Semicarbazone derivatives and their use as thrombopoietin mimetics
05/17/2001WO2001034584A1 Metal complexes and process for the preparation thereof
05/17/2001WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists
05/17/2001WO2001034573A1 Compounds
05/17/2001WO2001034148A1 Solid preparations for oral use
05/17/2001WO2001034135A2 Oncolytic combinations for the treatment of cancer
05/17/2001WO2001005390A3 Method for treating chronic pain using mek inhibitors
05/17/2001CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists
05/17/2001CA2390789A1 Oncolytic combinations for the treatment of cancer
05/17/2001CA2390557A1 Solid preparations for oral use
05/17/2001CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/16/2001EP1098891A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
05/16/2001EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/16/2001EP1098647A1 Compounds and compositions for treating tissue ischemia
05/16/2001EP1098638A1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart
05/16/2001EP1039886A4 Hiv/fiv protease inhibitors having a small p3 residue
05/16/2001EP0882719B1 Arylethenesulfonamide derivatives and drug composition containing the same
05/16/2001EP0842165B1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
05/16/2001CN1295576A Process for purification of cephalosporin derivative
05/16/2001CN1295548A Novel tricyclic compound
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor
05/16/2001CN1065863C N-substituted dioxothiazolidylbenzamide derivatives and process for producing same
05/15/2001US6232498 Process for the preparation of benzothiazolone compounds
05/15/2001US6232342 Protease inhibitors
05/15/2001US6232330 Therapeutically effective amount of an insulin sensitivity enhancer(pioglitazone,troglitazone and salts) in combination with an aldose reductase inhibitor(tolurestat,epalrestat,imirestat,zenarestat)
05/15/2001US6232328 Non-systemic control of parasites
05/15/2001US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/15/2001US6231786 Fluorinated azoles, and their use in liquid-crystalline mixtures
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/10/2001WO2001032638A1 Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
05/10/2001WO2001032636A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators
05/10/2001WO2001032609A1 Novel compounds having cyano and insecticides and miticides
05/10/2001WO2001032604A1 Activators of soluble guanylate cyclase
05/10/2001WO1999002514A3 Epothilone derivatives
05/10/2001DE19953136A1 Benzoylcyclohexandione und Benzoylpyrazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren Benzoylcyclohexanediones and benzoylpyrazoles, processes for their preparation and their use as herbicides and plant growth regulators
05/10/2001CA2397361A1 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation and their use as herbicides and plant growth regulators
05/10/2001CA2389773A1 Activators of soluble guanylate cyclase
05/10/2001CA2389703A1 Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
05/09/2001EP1097929A1 Amino acid derivatives and drugs containing the same as the active ingredient
05/09/2001EP1097925A1 Novel benzoic acid derivatives and processes for the preparation thereof
05/09/2001EP1097148A2 Polymorph of ritonavir
05/09/2001EP1097147A1 Novel angiogenesis inhibitors
05/09/2001EP1097128A1 Imidamide derivatives
05/09/2001EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/09/2001CN1294580A Indole derivatives with antiviral activity
05/09/2001CN1294126A Fluoric derivative of N-phenyl-2-oxazolylamine (thiazolylamine) and its preparing process and application
05/09/2001CN1065532C Thiazolidine and oxaxoliding derivatives, their prepn. and their medical use
05/09/2001CN1065531C Aminotetrazole derivatives useful as nitric oxide synthase inhibotors
05/08/2001US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors
05/08/2001US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups
05/08/2001US6228848 3-(1-propen-3-oxo)-5,6-dihydronaphthalene derivatives; side effect reduction
05/08/2001CA2032330C Benzyl-substituted rhodanine derivatives for treating inflammatory bowel disease
05/03/2001WO2001030771A1 Thiazolidinedione derivatives
05/03/2001WO2001030757A1 Drug discharge pump inhibitors
05/03/2001WO2001030749A1 Novel compounds
05/02/2001EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
05/02/2001EP1095930A1 Novel compounds
05/02/2001EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP1094811A1 New use
05/02/2001EP1094810A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation
05/02/2001EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
05/02/2001EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
05/02/2001EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/02/2001EP0946097B1 Composition and use
05/02/2001CN1293672A Process for preparation of nitrofuanidine derivatives
05/02/2001CN1293666A Benzenesulfonamide-derivatives and their use as medicaments
05/02/2001CN1293179A New method of preparing Latif alcohol derivative
05/01/2001US6225474 Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection
05/01/2001US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis